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ABSTRACT
Preeclampsia (PE) and intrauterine growth retardation (IUGR) are rare but severe pregnancy
complications that are associated with placental insufficiency often resulting in premature birth. The
clinical pathologies are related to gross placental pathologies and trophoblastic deficiencies that
might derive from inflammatory processes and oxidative stress injury. The mesenchymal core of
placental villi has been identified as a possible niche for trophoblast progenitor cells that are called
upon to replenish the injured syncytiotrophoblast layer. These progenitor cells are known to
express trophoblast stem cell (CDX2) and pluripotency (SOX2, NANOG and OCT4A) markers,
however only little data is available characterizing the expression of these transcription factors
beyond the blastocyst stage. We aimed to describe the expression of these factors in healthy 1st
and 3rd trimester placentae as well as PE, IUGR and combined PECIUGR placentae. We analyzed 8
respective samples derived from 1st trimester (elective abortions), and 3rd trimester (healthy
controls, PE, IUGR and combined PECIUGR). We accomplished immunoperoxidase staining to
detect the stem cell markers: CDX2 (trophectoderm), SOX2, NANOG and OCT4A (embryonal).
Immunoreative scoring was used for objective analyses of staining patterns. All markers display
clearly elevated signals in 1st trimester villous samples as compared to healthy 3rd trimester
counterparts. Especially CDX2 and NANOG were specific to the cytotrophoblast layer and the
mesenchymal core. Specific and differential expression patterns were visible in the villous/
extravillous compartment of each placenta-associated pregnancy complication (PE: pan elevated
expression; IUGR elevated SOX2 in basal plate; combined PECIUGR pan loss of expression).
Reduction of stem cell transcription factor expression in term placentae indicates temporal
regulation, and probably a specific function which is yet to be elucidated. The differential
expression patterns within placentae complicated with placenta-associated pregnancy
complications indicate that PE, IUGR and combined PECIUGR are separate entities. It is unclear







Preeclampsia is a potentially lethal syndrome that affects
6–8 % of all pregnancies and accounts for approximately
15% of all maternal deaths worldwide.1 Although much
debate exists on defining the exact pathomechanism, it is
generally accepted that the placenta is the main culprit
in triggering this disease, because only removal of the
placenta amounts to causal therapy.
PE is often thought of as a multi-step disease with the
first trimester setting the premises for the onset of the
disease in the latter 2 trimesters (reviewed in ref. 2). One
commonly accepted hypothesis puts forward that
shallow or defective extravillous trophoblast invasion
into the decidua during the first trimester, and thus
insufficient transformation of deep maternal spiral arter-
ies into low-resistant conduits, leads to suboptimal flow
of maternal blood into the intervillous space, thus nega-
tively altering the intervillous environment, which results
in syncytial stress (in the syncytiotrophoblast) during the
remaining 2 trimesters, which in turn triggers several
mechanisms that are thought to cause PE symptoms
and/or intrauterine growth retardation (IUGR).2-5
This hypothesis has been challenged recently by
Huppertz et al. who recognizes that many PE-associated
CONTACT Justine S. Fitzgerald Justine-Sayuri.Fitzgerald@med.uni-jena.de Deptartment of Obstetrics, Placenta Lab, University Hospital Jena,
Bachstrasse 18, 07743 Jena, Germany.
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changes are found before placentation is completed, thus
indicating that problematic early trophoblast differentia-
tion processes are instead associated with these complica-
tions.6,7 According to this newer train of thought, faulty
differentiation into extravillous trophoblast results in shal-
low invasion that is explanatory more for IUGR, while PE
is associated more with problematic syncytiotrophoblast
differentiation. When both PE and IUGR coincide, then
the trauma might have occurred during an even earlier
stage of trophoblast differentiation, during which both the
syncytio-, as well as the extravillous trophoblast popula-
tions derived from the same precursor.6
In any case, several kinds of stress have been described
to prevail in the villous compartment of the placenta
during PE: oxidative stress,3 inflammation7 and endothe-
lial dysfunction.8 Local stress during PE takes its toll on
the syncytiotrophoblast, leading to a higher rate of
cellular turnover that must be replenished by the layer of
villous cytotrophoblast just below the syncytial layer.9-11
Villous cytotrophoblast cells are often considered a tro-
phoblast stem cell, because this cell is able to differentiate
into any other trophoblast population, but probably
derive from a further progenitor for which the mesen-
chymal compartment of villi and chorion is the proposed
niche, at least during the first trimester of pregnancy, but
possibly in late gestation as well.12 Aberrant function of
villous cytotrophoblast and chorionic mesenchymal
stroma (or stem-like cells derived from human chorionic
mesenchym, as termed by some groups) has been impli-
cated in the development of PE characteristics.13-15
A commonly utilized marker of trophoblast stem/pro-
genitor cells, CDX2, is also one that is thought to specify
toward a trophoblast fate. These cells16 and villous mes-
enchymal stem/stroma cells have been described as
expressing so-called pluripotency markers such as
OCT4A, SOX2 and NANOG.13,17-19 More descriptive lit-
erature concerning the expression of all of these
transcription factors (both trophoblast, as well as mesen-
chymal) is mainly restricted to the preimplantation
phase and/or the murine model. Furthermore, to our
knowledge, the expression profile of any of these markers
has not been investigated in placenta-associated preg-
nancy pathologies such as PE and IUGR.
Taking into consideration that trophoblast progenitor
cells, possibly derived from the mesenchymal compart-
ment of the chorionic villi, would be called on to compen-
sate the stressed syncytium or extravillous compartment
in some way, we aimed here to characterize the expression
of all above-mentioned progenitor cell markers during the
course of a healthy pregnancy and compare that to said
expression profiles during placenta-associated pregnancy
pathologies, namely PE or IUGR or both.
Material and methods
Patient material
All samples of placental tissues were obtained from the
Department of Obstetrics of the University Hospital Jena
or from the Department of Obstetrics and Gynecology of
the Ludwig Maximillian University in Munich after
informed consent and after respective local Ethics Com-
mittee approval.
Women donated their placentae following prospective
inclusion to the study subsequent to either receiving an
elective abortion during the 1. trimester (5.-12. gesta-
tional weeks [GW], n D 8) in an otherwise healthy
pregnancy, delivering at term after a healthy pregnancy
(>36. GW; 39.2 GW, n D 8), after a pregnancy compli-
cated by third trimester PE with IUGR (>30. GW;
30.9 GW, n D 8; average birth weight 1109 g) or IUGR
alone (> 30. GW; 31.6 GW, n D 8; average birth weight
1410 g) or PE alone (>30. GW; 35.0 GW, n D 9; average
birth weight 2138 g).
Diagnosis of preeclampsia (PE) was based on the
guidelines as recommended by the German Society of
Obstetrics and Gynecology (DGGG): hypertension, as
measured by systolic blood pressure 140 mmHg and /
or diastolic blood pressure 90 mmHg measured twice
at an interval between 6 hours and 1 week, or singular
measurement 150 / 100 mmHg; and proteinuria as
measured by a urine dipstick test 1C or 300 mg total
protein in 24-hour urine collection. Intrauterine growth
retardation (IUGR) was diagnosed when birth weight
<10th percentile according to Voigt in a pregnancy in
which gestational age and normal fetal morphology was
confirmed in the first trimester and in which placental
insufficiency was confirmed via elevated pulsatility index
(PI) in the uterine arteries (>90th centile of reference
population).
Exclusion criteria for all patients were the existence of
potentially confounding factors such as multiple preg-
nancy, chromosomal and syndromal disorders, congeni-
tal infections, e.g. TORCH, amnion infection syndrome,
fetal alcohol syndrome and/or maternal substance abuse
(including nicotine), maternal diabetes mellitus or
gestational diabetes, and inborn or acquired disorders
leading to growth restriction in childhood.
All control term patients gave birth to infants that
were considered appropriate-for-gestational age. All con-
trol patients of the first trimester group presented at 5th
– 12th GW with vital pregnancies without any obvious
fetal malformations as identified via transvaginal sonog-
raphy and with the wish for an elective abortion due to
sociopsycho- or economic reasons and not due to
maternal health issues. Only third trimester pregnancies
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of both pregnancy pathology groups were included into
the study.
Immunohistochemistry
In order to decipher the localization, expression pattern
and expression intensity alterations of the target proteins
during the course of normal pregnancy and in pregnan-
cies complicated by either PE or IUGR, we employed
immunohistochemistry as previously described.20
Briefly, all tissues were fixed in 4% buffered formalin
for 20–24 hours, embedded in paraffin, then cut into
5mm sections and mounted on SuperFrost/Plus slides
(Menzel, Germany). The samples were then deparaffi-
nized and rehydrated. To inhibit endogenous peroxidise
activity, placenta tissues were incubated in methanol/
H2O2 for 30 min and washed for 5 min in phosphate-
buffered saline (PBS, pH 7.4). Antigenetic retrieval was
accomplished with citrate buffer. To reduce non-specific
background staining, all samples were incubated with
human serum (Typ AB, PAA, # C11-062) as recom-
mended by Honig et al.21 and as confirmed for study rel-
evant antibodies by Weber et al.22 as well as goat serum
at room temperature for 20 min (Vector Laboratories).
Tissues were incubated with primary antibodies (Table 1)
for 1 hour at room temperature. Antibodies were diluted
in DAKO Antibody Diluent with Background Reducing
Components (DAKO, #S3022). In a next step they were
incubated with the biotinylated secondary antibody
(Vector Laboratories) again for 30 min at room tempera-
ture. For a listing of all antibodies, please refer to Table 1.
Following incubation with the secondary antibody, an
incubation period with ABC-Complex (avidin-biotiny-
lated peroxidise; Vector Laboratories) for 30 min at
room temperature was completed. Between each step, all
samples were washed profusely with PBS. The peroxidase
reaction was achieved with DAB (diaminobenzidine/
H2O2; 1mg/ml; Vector Laboratories) and, after 5 minutes,
discontinued with water. Haematoxylin staining was fol-
lowed by mounting the cover slide with Histofluid.
A negative control was prepared by replacing the pri-
mary antibody with a DAKO control antibody with the
same isotype compared to the primary antibody in dilu-
ent. Please refer to Table 1 for isotype control.
All samples were analyzed with a Zeiss microscope
and statistical analyses were performed with the immu-
noreactive score (IRS) system.
The IR score was calculated by multiplication of opti-
cal staining intensity (grading of staining intensity: 0-
none, 1- weak, 2-moderate, 3-strong) and percentage of
positive cells stained (grading for percentage of stained
cells: 0- none, 1- under 10% of cells, 2- up to 50%, 3- up
to 80%, 4- up to 100%). Samples were studied by 3
blinded, independent scorers, who were not given any
prior information of diagnosis or staining target. The
IRS score is a fair indicator for the intensity of protein
expression in a certain tissue.
Only nuclear staining of SOX2, OCT4A, NANOG and
CDX2 was considered for the IRS score. One full-thick-
ness walnut-sized sample per placenta was taken from
an area at the midpoint between umbilical cord and pla-
cental rim. In all, 10 areas per sample were considered
for IRS analysis.
Statistical analysis
The SPSS/PC software package, version 17 (SPSS,
Munich, Germany) was used for collection, processing
and statistical analysis of all data. Statistical analysis was
performed using the nonparametrical Wilcoxon-Mann-
Whitney test for comparison of the IRS score distribu-
tion. P < 0.05 values were considered statistically
significant.
Results
CDX2, NANOG, SOX2 and OCT4A staining in the vil-
lous compartment is clearly elevated in the first trimester
as compared to the healthy third trimester.
The villous compartment of first trimester placentas
stained positively for all markers investigated in this
study, while staining in the same compartment was sig-
nificantly lower for the same markers in third trimester
samples. Some nuclei of the syncytiotrophoblast layers of
the first trimester placenta stained positive for CDX2
and NANOG, however these proteins showed an alto-
gether more mosaic type pattern within the villous and
in several areas it seemed that especially the
Table 1. Antibodies and kits.
Antibody Clone Isotype Concentration Source
CDX2 (Order#:3977) Polyclonal Rabbit 1: 200 Cell Signaling
SOX2 D6D9 (Order#:3579) Monoclonal Rabbit 1: 100 Cell Signaling
NANOG -(Order#:3580) Polyclonal Rabbit 1: 400 Cell Signaling
OCT4A C52G3 (Order#:2890) Monoclonal Rabbit 1: 300 Cell Signaling
Isotype control Clone DA1E (Order#:3900) Monoclonal Rabbit 1: 100 Cell Signaling
ABC Elite-Kit (rabbit IgG) PK-6101 Vector Laboratories (L€orrach, Germany)
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cytotrophoblast layer expressed CDX2 and NANOG
(please refer to Fig. 1A and 1B, arrows pointing down-
ward). It was surprising to find that according to villous
morphology positive signals for OCT4A and SOX2 were
visible especially in the nuclei of the syncytiotrophoblast
layer (versus the cytotrophoblast) in first trimester pla-
centas (Fig. 1C and 1D).
Nuclei within the mesenchymal core generally stained
positive for CDX2 and NANOG in first trimester placen-
tae, while the other pluripotency markers, OCT4A and
SOX2, were usually negative (Fig. 1A-D, horizontal
arrows). For the sake of simplicity, we did not segregate
IRS scores of villous trophoblast and mesenchymal core,
especially since all signals were either significantly reduced
(CDX2, NANOG; statistics in Fig. 4A and 4B) or
completely eliminated (SOX2, OCT4A, statistics in
Fig. 3C and 3D) in the third trimester villous compart-
ment, both among the villous trophoblast, as well as
within the mesenchymal core (Fig. 1E-H).
Specific and differential expression patterns of CDX2,
NANOG, SOX2 and OCT4A is visible in the villous
compartment of all placenta-associated pregnancy com-
plications vs. healthy controls.
Following the hypothesis that PE pregnancy is associ-
ated with oxidative stress and inflammation that leads to
overly high syncytiotrophoblast turnover, we suspected
that any form of syncytiotrophoblast progenitor (such as
the cytotrophoblast or trophoblast progenitor cells of the
villous compartment) must be called on to replenish the
synctiotrophoblast layer. Indeed, in comparison to
healthy controls, we were able to confirm that CDX2,
SOX2 and OCT4 (but not NANOG) expression was sig-
nificantly elevated in PE cases (Fig. 2I-L vs. Fig. 1E-H).
Interestingly, the signals for CDX2 and NANOG,
which were diminished within the healthy third trimester
villous (Fig. 1E and 1F) had completely disappeared
within the villous of PECIUGR placentae (Fig. 2A and
2B). In contrast, pure IUGR cases did not differ signifi-
cantly in their marker expression pattern from healthy
controls (Fig. 2E and 2F vs. Fig. 1E and Fig. 1F).
The panels A-D in Figure 4 reiterates these descriptive
assertions as the statistical evaluation of blinded IRS
points. The p-value < 0.05 reveals significance for com-
parisons of both CDX2 and NANOG signals in healthy
3rd trimester villous vs. PECIUGR villous, during which
the signal is lost. The same panels in Figure 4 also dem-
onstrate that both CDX2 and NANOG signals tend to be
less visible in IUGR villous as compared to healthy third
trimester villous, but this does not reach statistical signif-
icance. It is of note that all investigated factors are ele-
vated in the villous compartment of pure PE placentae in
comparison to PECIUGR placentae. When comparing
Figure 1. IHC 1st vs. 3rd Trimester, villous sections. Diagonal arrows (&) indicate marker staining within the cytotrophoblast layer of the
villous. Horizontal arrows ( ,!) indicate marker staining in cells within the mesenchymal core of the villous. All investigated markers
are expressed within the villous of 1st trimester placentas (A-D). Especially CDX2 (A) and NANOG (B) appear to be expressed in the cyto-
trophoblast and villous mesenchymal core cell populations, while OCT4A (C) and SOX2 (D) appear to be expressed mainly in the cyto-
plasm of the syncytiotrophobast. Expression of all markers is markedly decreased (CDX2 and NANOG in E and F respectively) or lost
(OCT4A and SOX2 in G and H respectively) in the villous of healthy placentas. Scale bars indicate 50 mm.
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pure PE with pure IUGR, it becomes apparent that
CDX2 and SOX2 expression is diminished in IUGR
placentae.
The expression of SOX2 is elevated in the basal plate
of placentae complicated by IUGR versus control.
Nuclei of cells within the basal plate generally
remained signal negative for all investigated nuclear
transcription factors regardless of cell population or
pregnancy pathology (Fig. 3A-L). SOX2 nucleic staining
appeared distinctly positive in isolated cells within the
extravillous, basal plate section of pure IUGR cases
and statistical evaluation of IRS results revealed a signifi-
cantly higher SOX2 score in pure IUGR placentae
as compared to PECIUGR placentae (p D 0.036 in
Fig. 4G).
We had aimed to identify whether SOX2 staining was
within the extravillous trophoblast by employing CK7 as a
trophoblast marker in immunofluorescence experiments.
However, due to the fact that the SOX2 signals within
the extravillous compartment were elevated only in iso-
lated cells of IUGR complicated placentae, it was difficult
to pinpoint these specific cells for IF staining in serial
sections (data not shown) so that currently, we are
unable to verify whether the few cells that stained
positive for SOX2 in PE extravillous cells were actually
trophoblast.
It is also of note that we were unable to process the
basal plate of pure PE cases due to technical difficulties
that had resulted in the loss of tissue.
Discussion
Our data demonstrates the expression of CDX2 and
NANOG especially in the cytotrophoblast, and OCT4A
and SOX2 in the syncytiotrophoblast of the villous com-
partment of first trimester placentas, while these markers
are reduced (CDX2 and NANOG) or nearly deleted
(SOX2 and OCT4) at the end of gestation. In the same
compartment of placentas complicated by PE and IUGR,
the CDX2 and NANOG signal is completely lost and
thus significantly altered in comparison to healthy third
trimester placentae. In pure PE cases, especially SOX2
Figure 2. IHC of PECIUGR versus PE vs. IUGR in 3rd trimester placental villous sections. Diagonal arrows (&) indicate marker staining
within the cytotrophoblast layer of the villous. Horizontal arrows ( ,!) indicate marker staining in cells within the mesenchymal core
of the villous. None of the investigated markers are visible in any part of the combined preeclampsia C intrauterine growth retardation
(PECIUGR) -altered placental villous (A-D). Staining of CDX2 (E) and NANOG (F) are weak in the villous (both cytotrophoblast and mesen-
chymal core cells) of placentas derived from pregnancies complicated by intrauterine growth retardation, while OCT4A (G) and SOX2 (H)
are not detecable. This staining pattern is similar to that seen in the villous placenta of healthy third trimester pregnancies. In pre-
eclampsia villous, all investigated markers are detectable in the mesenchymal core and often in the villous cytotrophoblast (I-L). This
staining pattern is more similar to that seen in the villous placenta of healthy first trimester pregnancies. Scale bars indicate 50 mm.
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and OCT4 staining within the mesenchymal core of cho-
rionic villi is elevated. The SOX2 signal was significantly
elevated in the basal plate of pure IUGR-complicated
placentae vs. their healthy counterparts.
Ergo, In summary, we demonstrate that there is a
unique staining pattern of trophoblast progenitor cell –
and pluripotency markers at different timepoints of the
healthy placenta and within each observed pathology
associated with the placenta (PE, IUGR and PECIUGR).
This suggests that the investigated markers hold a tri-
mester-dependent function, the deregulation of which
would lead to separate, although clinically similar,
pathologies.
Before we discuss the above-mentioned denotations,
we first extend our attention to several points pertaining
the reliability of our results.
Although other studies have described the expression
of these markers in the first trimester placenta and dur-
ing the course of pregnancy, our study is the first in
which this was accomplished comprehensively and with
visual verification of protein localization. Two groups
demonstrated CDX2 expression in the first trimester
cytotrophoblast, which was lost in late gestation.12,16
Some demonstrated similar findings for cytotrophoblas-
tic NANOG expression.17,23 Others found cells derived
from the chorion (with various terminology: mesenchy-
mal stem cells, mesenchymal stromal cells, chorionic
stem cells) that expressed some or all of the pluripo-
tency-associated markers, OCT4A, SOX2 and
NANOG.13,18,19 One group demontrated that first tri-
mester placentae expressed higher levels of pluripotency-
associated markers than those of third trimester placen-
tae19. The cumulative results of these studies reassure us
that our data concerning healthy pregnancies is reliable,
suggesting also that our staining procedure is sound.
The observation of pluripotency markers (OCT4A
and SOX2) in the cytoplasm of a terminally differenti-
ated cell (syncytiotrophoblast) was unexpected. This was
surprising for 2 reasons: (1) because pluripotency
markers usually disappear after differentiation and (2)
because these transcription factors are thought to be
active exclusively in the nucleus. The possibility of false
positive staining must be taken seriously, however, we
have taken all recommended precautions to minimize
this known phenomenon, e.g., by using a monoclonal
antibody specific to the N-terminus of OCT-4A,24 2 sep-
arate negative controls (omission of secondary antibody,
isotype control), and further experiment specific controls
(internal controls, use of both conventional, as well as
human serum blocking procedures22), making it unlikely
that our signals are false positive. Further analyses, e.g.
RT-PCR and Western blot might verify our results, albeit
these experiments would then disregard cell population.
Our samples were stored in formalin rendering them
improper for these procedures, but the literature interest-
ingly demonstrates cytoplasmic staining of some of these
markers in other cell populations25-28 and in non-human
trophoblastic cells.29,30 In our study, cytoplasmic staining
Figure 3. IHC of healthy vs. PE- and IUGR-derived placental extravillous sections. No positive staining for any of the investigated markers
is apparent in the extravillous of healthy placentas (I-L) or preeclampsia-altered placentas (A-D). Horizontal arrows (!) indicate marker
staining (SOX2) in cells within the extravillous section of placentas altered by intrauterine growth retardation (G). Further identification
of SOX2 positive cells was not possible; SOX2 expression was erratic and often not visible again in the serial section (data not shown).
Scale bars indicate 50 mm.
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of transcription factors was seen only in the terminally
differentiated STB, suggesting that functional differences
of these markers correlate to their position within the
cell. We suspect that OCT4 and SOX2 expression within
STB cytoplasm does not reflect pluripotent capacity, but
rather is a remnant of the CTB daughter cell life cycle
after fusion into the STB, meaning that OCT4/SOX2
expression has become redundant in the STB.
Figure 4. Statistical evaluation of IRS results. Statistical evaluation of IRS results recapitulates the observations described in Figures 1–3.
Expression of CDX2, NANOG, SOX2 and OCT4A is visible in the villous section of first trimester placentas (first lanes of A-D). Expression
of CDX2 and NANOG are significantly diminished in the villous section of healthy third trimester placentas (second lanes of A and B, p
respectively), while OCT4A and SOX2 signals are lost (second lanes of C and D, p respectively). No significant changes as compared to
healthy third trimester controls are visible in the villous of placentas derived from intra-uterine growth retardation complicated preg-
nancies (fourth lanes of A-D), while CDX2 and NANOG expression are lost in preeclampsia-altered villous placentas (third lanes in A and
B, p respectively), and thus significantly altered as compared to healthy controls.Only SOX2 expression is altered in any of the investi-
gated extravillous placental sections. In this case, SOX2 expression is significantly elevated in the extravillous of intrauterine growth
retardation-derived placentas as compared to healthy third trimester controls (G, p).
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Our final point concerning reliability is the questio-
nablity of comparing placental material with gestational
age disparity. Albeit still stemming from the same tri-
mester, the gestational age descripancy in the case groups
versus the control group is up to 9 weeks. The manifesta-
tion of severe PE C IUGR is rare in late gestation as they
are usually terminated in the second trimester (before
the 30th GW) before becoming life-threatening to
mother and child. Finding an appropriate control group
for 2nd trimester placentae is difficult as extreme prema-
turity is potentially confounding in itself. Our compro-
mise included all cases in the third trimester thus
lowering the gestational age discrepancy, while maintain-
ing clear diagnostic criteria. However, since the case pla-
centas derive from similar GWs, but display staining
distinction between subgroups, it seems unlikely that the
observed differences are due to gestational age alone.
Now that we have adressed certain methodoligical
arguments, we discuss the observed results.
As this is an observational study, we can only specu-
late as to why the first trimester trophoblast (including
chorionic mesenchymal cells), seems to express pluripo-
tency factors, or why this expression is lost at the end of
gestation, however it is likely due to STB expansion.
According to newer models of STB renewal, the STB
layer is replenished by the underlying CTB layer, which
in turn is probably replenished by pluripotency marker-
expressing cells within the chorionic mesenchymal core,
which can also replenish all other trophoblast popula-
tions, such as the invasive EVT, but also the STBs.12 For
the sake of simplicity, we will term these cells “tropho-
blast progenitor cells” from here on. Syncytium expan-
sion is at its highest during the first trimester of
pregnancy, meaning that villous CTBs and trophoblast
progenitor cells must constantly supply the syncytium
with further STBs in order to accommodate the develop-
ment of this layer. This is accomplished by fusion of an
underlying villous CTB (or trophoblast progenitor cell)
daughter cell with the syncytium.11 According to our
observations, it is tempting to hypothesize that CDX2
and NANOG work in concert during villous CTB or tro-
phoblast progenitor cell production of daughter cells. In
the third trimester, syncytium expansion is arrested so
villous CTBs need only to maintain the status quo, which
explains the decrease or loss of trophoblast progenitor-
and pluripotency marker signals in the villous compart-
ment of third trimester placentae.
The observed elevation of the investigated markers in
the villous of PE complicated pregnancies was expected,
because, as reviewed in ref. 11, the STB within a pure PE
placenta is stressed therefore cellular turnover is elevated,
resulting in higher villous CTB proliferation and STB
differentiation. This train of thought is mirrored in our
study, since most investigated markers were elevated
during PE in comparison both to healthy counterparts
and pure IUGR placentas. The observed loss of signals in
villous samples of combined PE C IUGR was unique
(not resembling pure IUGR nor pure PE) and
unexpected.
This is especially counterintuitive if the common
denominator of all 3 pathologies is thought to be defec-
tive extravillous trophoblast invasion, but not if all 3 sit-
uations are understood as separate entities with separate
formation mechanisims. Recent literature indicates that
although PE is often associated with IUGR and both
pregnancy pathologies originate from the placenta, they
are indeed 2 separate entities with separate origins.
Although STBs and EVTs have a common up-stream
precursor (trophoblast progenitor cells), they also proba-
bly differentiate from a separate set of intermediate pre-
cursor cells even late in pregnancy31, so, as Huppertz
et al has recently put forward, PE characteristics might
stem more from defective STB maturation processes,
while insufficiency of the placenta to produce invasive
extravillous trophoblast seems rather to lead to IUGR.
Combined PECIUGR possibly occurs when the common
upstream precursor, the trophoblast progenitor cell, is
defective. Recent publications suggest that functions
such as cytokine or exosomal secretion by chorionic
mesenchymal core cells, possibly trophoblast progenitor
cells, is negatively altered in PE placentas and thus con-
tributes to main PE characteristics, indicating that these
cells react in a destructive manner to their environ-
ment.13-15 According to our data, it appears that the tro-
phoblast progenitor cells overexpress several
(trophoblast) progenitor cell markers during pure PE,
while these are underexpressed during PE C IUGR.
Ergo, our results are better explained by the PE/IUGR-
hypotheses provided by Huppertz et al.
Functionally speaking, we suspect that lack of (tro-
phoblast) progenitor cell marker expression the tropho-
blast progenitor cells of PECIUGR indicates its inablity
to react to the dire intervillous environment, which exists
in all PE cases, a situation that might contribute to the
further exacerbation of PE by triggering IUGR. Further
studies are necessary to prove whether this train of
thought has merit. We wish to stress here that older, in-
house results demonstrate significantly lower expression
of another molecule associated with pluripotency,
STAT3 (Signal Transducer and Activator of Transcrip-
tion 3), in PECIUGR placentae.32
In this context, it is noteworthy that significant differ-
ences in SOX2 staining was visible in the (extravillous)
basal plate compartment of pure IUGR complicated
pregnancies. This observation is also congruent with the
above theory by Huppertz et al, as this implies that some
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sort of progenitor cell action is taking place in an extra-
villous portion of IUGR complicated pregnancies.
Taken together, the results of our study indicate that
PE, IUGR and combined PECIUGR are 3 separate enti-
ties in which trophoblast differentiation processes are
uniquely abberant, however we are unable to maintain
whether this observation is the cause or the symptom of
the pathology.
Conclusions
We conclude that trophobalst stem cell and pluripotency
markers are expressed in specific cell populations of the
early placenta and down-regulated later on in pregnancy.
Out of the observation that placentas altered by
PECIUGR are not able to express some of these markers
(CDX2, NANOG), while pure PE, pure IUGR and con-
trol placentas are, we speculate that these 3 entities have
differing pathogeneses. Due to the fact that these marker
expression differences are seen mainly in the villous
cytotrophoblast and villous mesenchymal core cells,
which are now considered trophoblast progenitor cells,
we speculate that these cell populations are functionally
perturbed in PE C IUGR placentas.
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